Cathie Wood's ARK ETFs have made their daily trades public for Thursday, January 23rd, 2025, displaying a strategic shift in their portfolio holdings. The trades indicate a continued interest in biotech with a notable sell-off in the healthcare services sector.

Cathie Wood-led Ark Invest made significant trades involving ACCD, DE, NTLA, PATH, CCJ, OKLO, ILMN, ESLT, and ABSI.

Asset management company Ark Invest offers nine different investment funds, eight of which are available as exchange-traded funds, or ETFs. There are other ETFs with similar specialties. In other words,

Cathie Wood is betting Donald Trump’s regulatory and growth agenda will revive the market for US initial public offerings.

Investing guru Cathie Wood remains an investor favorite. Although the founder of the ARK Invest family of exchange-traded funds (ETFs) lost to the market in 2024, it was not an even performance.  Where her flagship ARK Innovation ETF (NYSEARCA:ARKK) only gained 12% last year versus the 24% rise by the S&P 500,

Cathie Wood, chief executive of Ark Investment Management, frequently buys technology stocks that she says will disrupt a number of sectors. Sometimes, her strategy pays off: The flagship Ark Innovation ETF ( ARKK) has gained 5% this year as of Jan. 17, outperforming the S&P 500 and the Nasdaq Composite.

Cathie Wood and Warren Buffett may have vastly different investment philosophies, but each investor holds a position in a relatively unknown rising star in the fintech space.

In the latest series of trades from Cathie Wood's ARK ETFs, investors witnessed a mix of buying and selling across various sectors for Wednesday, 22 January 2025. The most significant move was the sale of Robinhood Markets Inc (NASDAQ:HOOD) shares,

Cathie Wood is the CEO and chief investment officer of Ark Invest. Over the last several years, she has earned a reputation for making overly bullish calls on companies that may typically lack the full attention of the rest of Wall Street.